116 related articles for article (PubMed ID: 19882513)
1. Sustained regression of florid diabetic retinopathy in a patient with Donohue syndrome (leprechaunism).
Casati S; Zoppini G; Muggeo M; Marchini G
Eur J Ophthalmol; 2010; 20(1):224-7. PubMed ID: 19882513
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of navigated panretinal photocoagulation in proliferative diabetic retinopathy.
Chhablani J; Sambhana S; Mathai A; Gupta V; Arevalo JF; Kozak I
Am J Ophthalmol; 2015 May; 159(5):884-9. PubMed ID: 25703478
[TBL] [Abstract][Full Text] [Related]
3. Retinal neovascularization during treatment with IGF-1 for insulin resistance syndrome.
Kitamei H; Yokoi M; Kase M; Ohno S
Graefes Arch Clin Exp Ophthalmol; 2005 Jul; 243(7):715-7. PubMed ID: 15672252
[TBL] [Abstract][Full Text] [Related]
4. Single-session vs multiple-session pattern scanning laser panretinal photocoagulation in proliferative diabetic retinopathy: The Manchester Pascal Study.
Muqit MM; Marcellino GR; Henson DB; Young LB; Patton N; Charles SJ; Turner GS; Stanga PE
Arch Ophthalmol; 2010 May; 128(5):525-33. PubMed ID: 20457972
[TBL] [Abstract][Full Text] [Related]
5. [Comparative use of diode and argon laser for panretinal photocoagulation in diabetic retinopathy].
Ulbig MW; Hamilton AM
Ophthalmologe; 1993 Oct; 90(5):457-62. PubMed ID: 8219631
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal bevacizumab versus panretinal photocoagulation for treatment-naïve proliferative and severe nonproliferative diabetic retinopathy.
Ernst BJ; García-Aguirre G; Oliver SC; Olson JL; Mandava N; Quiroz-Mercado H
Acta Ophthalmol; 2012 Nov; 90(7):e573-4. PubMed ID: 22405048
[No Abstract] [Full Text] [Related]
7. Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study).
Figueira J; Fletcher E; Massin P; Silva R; Bandello F; Midena E; Varano M; Sivaprasad S; Eleftheriadis H; Menon G; Amaro M; Ayello Scheer S; Creuzot-Garcher C; Nascimento J; Alves D; Nunes S; Lobo C; Cunha-Vaz J;
Ophthalmology; 2018 May; 125(5):691-700. PubMed ID: 29395119
[TBL] [Abstract][Full Text] [Related]
8. Randomized comparison of krypton versus argon scatter photocoagulation for diabetic disc neovascularization. The Krypton Argon Regression Neovascularization Study report number 1.
Ophthalmology; 1993 Nov; 100(11):1655-64. PubMed ID: 8233391
[TBL] [Abstract][Full Text] [Related]
9. Interim Safety Data Comparing Ranibizumab With Panretinal Photocoagulation Among Participants With Proliferative Diabetic Retinopathy.
Gross JG; Glassman AR; Klein MJ; Jampol LM; Ferris FL; Bressler NM; Beck RW
JAMA Ophthalmol; 2017 Jun; 135(6):672-673. PubMed ID: 28492921
[TBL] [Abstract][Full Text] [Related]
10. Effect of panretinal photocoagulation treatment on vision-related quality of life of patients with proliferative diabetic retinopathy.
Tsilimbaris MK; Kontadakis GA; Tsika C; Papageorgiou D; Charoniti M
Retina; 2013 Apr; 33(4):756-61. PubMed ID: 23190918
[TBL] [Abstract][Full Text] [Related]
11. Repeated intravitreal bevacizumab (Avastin(®)) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation.
Schmidinger G; Maar N; Bolz M; Scholda C; Schmidt-Erfurth U
Acta Ophthalmol; 2011 Feb; 89(1):76-81. PubMed ID: 21272288
[TBL] [Abstract][Full Text] [Related]
12. Ten-year improvement of insulin resistance and growth with recombinant human insulin-like growth factor 1 in a patient with insulin receptor mutations resulting in leprechaunism.
de Kerdanet M; Caron-Debarle M; Nivot S; Gaillot T; Lascols O; Fremont B; Bonaure M; Gie S; Massart C; Capeau J
Diabetes Metab; 2015 Sep; 41(4):331-337. PubMed ID: 25465274
[TBL] [Abstract][Full Text] [Related]
13. Multimodal characterization of proliferative diabetic retinopathy reveals alterations in outer retinal function and structure.
Boynton GE; Stem MS; Kwark L; Jackson GR; Farsiu S; Gardner TW
Ophthalmology; 2015 May; 122(5):957-67. PubMed ID: 25601533
[TBL] [Abstract][Full Text] [Related]
14. "Geyser" leakage on fluorescein angiography.
Levy J; Fagan XJ; Lifshitz T; Schneck M
Ophthalmic Surg Lasers Imaging Retina; 2013 Nov; 44 Online():E23. PubMed ID: 24548789
[TBL] [Abstract][Full Text] [Related]
15. [Laser treatment in diabetic retinopathy].
Dumitrache M; Aniţescu M; Cârstocea B
Oftalmologia; 1995; 39(2):159-69. PubMed ID: 7766596
[TBL] [Abstract][Full Text] [Related]
16. Retinal blood flow regulation and the clinical response to panretinal photocoagulation in proliferative diabetic retinopathy.
Grunwald JE; Brucker AJ; Petrig BL; Riva CE
Ophthalmology; 1989 Oct; 96(10):1518-22. PubMed ID: 2587047
[TBL] [Abstract][Full Text] [Related]
17. Extended targeted retinal photocoagulation versus conventional pan-retinal photocoagulation for proliferative diabetic retinopathy in a randomized clinical trial.
Nikkhah H; Ghazi H; Razzaghi MR; Karimi S; Ramezani A; Soheilian M
Int Ophthalmol; 2018 Feb; 38(1):313-321. PubMed ID: 28168567
[TBL] [Abstract][Full Text] [Related]
18. Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy.
Filho JA; Messias A; Almeida FP; Ribeiro JA; Costa RA; Scott IU; Jorge R
Acta Ophthalmol; 2011 Nov; 89(7):e567-72. PubMed ID: 21726427
[TBL] [Abstract][Full Text] [Related]
19. Full panretinal photocoagulation and early vitrectomy improve prognosis of florid diabetic retinopathy.
Favard C; Guyot-Argenton C; Assouline M; Marie-Lescure C; Pouliquen YJ
Ophthalmology; 1996 Apr; 103(4):561-74. PubMed ID: 8618753
[TBL] [Abstract][Full Text] [Related]
20. Prediction of regression of retinal neovascularisation after panretinal photocoagulation for proliferative diabetic retinopathy.
Chatziralli IP; Sergentanis TN; Sivaprasad S
Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1715-21. PubMed ID: 26802035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
